These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 14966121)
21. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes. Axlund SD; Lambert JR; Nordeen SK Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772 [TBL] [Abstract][Full Text] [Related]
22. Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase. Lee LF; Guan J; Qiu Y; Kung HJ Mol Cell Biol; 2001 Dec; 21(24):8385-97. PubMed ID: 11713275 [TBL] [Abstract][Full Text] [Related]
23. Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells. Lin HK; Altuwaijri S; Lin WJ; Kan PY; Collins LL; Chang C J Biol Chem; 2002 Sep; 277(39):36570-6. PubMed ID: 12119296 [TBL] [Abstract][Full Text] [Related]
24. An androgen receptor NH2-terminal conserved motif interacts with the COOH terminus of the Hsp70-interacting protein (CHIP). He B; Bai S; Hnat AT; Kalman RI; Minges JT; Patterson C; Wilson EM J Biol Chem; 2004 Jul; 279(29):30643-53. PubMed ID: 15107424 [TBL] [Abstract][Full Text] [Related]
25. Implications of a polyglutamine tract in the function of the human androgen receptor. Callewaert L; Christiaens V; Haelens A; Verrijdt G; Verhoeven G; Claessens F Biochem Biophys Res Commun; 2003 Jun; 306(1):46-52. PubMed ID: 12788064 [TBL] [Abstract][Full Text] [Related]
26. Cyclin G-associated kinase: a novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer. Ray MR; Wafa LA; Cheng H; Snoek R; Fazli L; Gleave M; Rennie PS Int J Cancer; 2006 Mar; 118(5):1108-19. PubMed ID: 16161052 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Irvine RA; Ma H; Yu MC; Ross RK; Stallcup MR; Coetzee GA Hum Mol Genet; 2000 Jan; 9(2):267-74. PubMed ID: 10607837 [TBL] [Abstract][Full Text] [Related]
28. Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer. Yeh S; Sampson ER; Lee DK; Kim E; Hsu CL; Chen YL; Chang HC; Altuwaijri S; Huang KE; Chang C J Formos Med Assoc; 2000 Dec; 99(12):885-94. PubMed ID: 11155740 [TBL] [Abstract][Full Text] [Related]
29. Domain interactions between coregulator ARA(70) and the androgen receptor (AR). Zhou ZX; He B; Hall SH; Wilson EM; French FS Mol Endocrinol; 2002 Feb; 16(2):287-300. PubMed ID: 11818501 [TBL] [Abstract][Full Text] [Related]
30. ZMIZ1 preferably enhances the transcriptional activity of androgen receptor with short polyglutamine tract. Li X; Zhu C; Tu WH; Yang N; Qin H; Sun Z PLoS One; 2011; 6(9):e25040. PubMed ID: 21949845 [TBL] [Abstract][Full Text] [Related]
31. 2,2-bis(4-chlorophenyl)-1,1-dichloroethylene stimulates androgen independence in prostate cancer cells through combinatorial activation of mutant androgen receptor and mitogen-activated protein kinase pathways. Shah S; Hess-Wilson JK; Webb S; Daly H; Godoy-Tundidor S; Kim J; Boldison J; Daaka Y; Knudsen KE Mol Cancer Res; 2008 Sep; 6(9):1507-20. PubMed ID: 18819937 [TBL] [Abstract][Full Text] [Related]
32. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells. Fujimoto N; Miyamoto H; Mizokami A; Harada S; Nomura M; Ueta Y; Sasaguri T; Matsumoto T Cancer Invest; 2007 Feb; 25(1):32-7. PubMed ID: 17364555 [TBL] [Abstract][Full Text] [Related]